1. Daiichi Sankyo Co. Ltd.
2. Hisamitsu Pharmaceutical Co. Inc.
3. Orexo AB
4. Pfizer Inc
5. Teva Pharmaceutical Industries Limited
6. Sanofi
7. Johnson & Johnson
8. Eli Lilly
Published | Pages | Publisher | Report code |
---|---|---|---|
Apr 2023 | 450 | Renub Research | ASDR-620393 |
1. Daiichi Sankyo Co. Ltd.
2. Hisamitsu Pharmaceutical Co. Inc.
3. Orexo AB
4. Pfizer Inc
5. Teva Pharmaceutical Industries Limited
6. Sanofi
7. Johnson & Johnson
8. Eli Lilly